Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

Product portfolio
Potentially strong market reviews
Competitive analytics
Prospect partners
Mergers and acquisitions project data
Latest trends across a particular industry area
Research and development strategies
The analysis of new customers
A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853

Sort by:

Interleukin 10 Receptor (IL10R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 10 Receptor (IL10R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 10 Receptor (IL10R) Drugs in Development by T...

May 2022 42 pages

Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Ind...

May 2022 89 pages

Interleukin 12 Receptor (IL12R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 12 Receptor (IL12R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 12 Receptor (IL12R) Drugs in Development by T...

May 2022 52 pages

Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Ind...

May 2022 40 pages

Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Ind...

May 2022 62 pages

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 15 Receptor Subunit A...

May 2022 62 pages

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleuk...

May 2022 57 pages

Interleukin 17F (Cytokine ML 1 or IL17F) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 17F (Cytokine ML 1 or IL17F) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 17F (Cytokine ML 1 or IL17F) Drugs i...

May 2022 37 pages

Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 37 pages

Interleukin 2 Receptor (IL2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Interleukin 2 Receptor (IL2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2 Receptor (IL2R) Drugs in Development by Thera...

May 2022 134 pages

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2...

May 2022 46 pages

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2 (T Cell Growth F...

May 2022 55 pages

Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 21 Rec...

May 2022 39 pages

Interleukin 22 Receptor (IL22R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 22 Receptor (IL22R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 22 Receptor (IL22R) Drugs in Development by T...

May 2022 39 pages

Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Ind...

May 2022 61 pages

Interleukin 23 Receptor (IL23R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 23 Receptor (IL23R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 23 Receptor (IL23R) Drugs in Development by T...

May 2022 36 pages

Interleukin 23 Subunit Alpha (Interleukin 23 Subunit p19 or IL23A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 23 Subunit Alpha (Interleukin 23 Subunit p19 or IL23A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 23 Subunit...

May 2022 52 pages

Interleukin 4 (B Cell Stimulatory Factor 1 or Binetrakin or Lymphocyte Stimulatory Factor 1 or Pitrakinra or IL4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 4 (B Cell Stimulatory Factor 1 or Binetrakin or Lymphocyte Stimulatory Factor 1 or Pitrakinra or IL4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...

May 2022 35 pages

Interleukin 4 Receptor Subunit Alpha (CD124 or IL4R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 4 Receptor Subunit Alpha (CD124 or IL4R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 4 Receptor Subunit Alpha...

May 2022 50 pages

Interleukin 5 (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 5 (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...

May 2022 36 pages

Interleukin 6 Receptor (IL6R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 6 Receptor (IL6R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 6 Receptor (IL6R) Drugs in Development by Thera...

May 2022 63 pages

Interleukin 7 (IL7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 7 (IL7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 7 (IL7) Drugs in Development by Therapy Areas and Indicat...

May 2022 36 pages

Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Ke...

May 2022 40 pages

Intermediate Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Intermediate Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Intermediate Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 37 pages

Interstitial Cystitis (Painful Bladder Syndrome-Bladder Pain Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Interstitial Cystitis (Painful Bladder Syndrome-Bladder Pain Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Interstitial Cystitis (Painful Bladder Sy...

May 2022 49 pages

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Interstitial Lung Diseases (Diffuse Parenchymal Lu...

May 2022 56 pages

Interstitial Lung Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Interstitial Lung Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Interstitial Lung Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 40 pages

Intracerebral Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Intracerebral Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Intracerebral Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 45 pages

Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 113 pages

Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 40 pages

Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 216 pages

Isocitrate Dehydrogenase [NADP] Mitochondrial (NADP(+)-Specific ICDH or Oxalosuccinate Decarboxylase or ICD M or IDP or IDH2 or EC 1.1.1.42) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Isocitrate Dehydrogenase [NADP] Mitochondrial (NADP(+)-Specific ICDH or Oxalosuccinate Decarboxylase or ICD M or IDP or IDH2 or EC 1.1.1.42) Drugs in Development by Therapy Areas and Indications, Stag...

May 2022 39 pages

Janus Kinase (JAK or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Janus Kinase (JAK or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Janus Kinase (JAK or EC 2.7.10.2) Drugs in Development...

May 2022 154 pages

Juvenile Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Juvenile Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Juvenile Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 38 pages

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Kappa Type Opioid Receptor (KOR1 or OP...

May 2022 124 pages

Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 35 pages

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) Dr...

May 2022 38 pages

Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 198 pages

Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ketohexokinase (Hepatic Fructo...

May 2022 36 pages

Klebsiella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Klebsiella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Klebsiella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 105 pages

Lafora Disease (Unverricht Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lafora Disease (Unverricht Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lafora Disease (Unverricht Disease) Drugs in Development by Stages, Target,...

May 2022 35 pages

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Laminin-Deficient...

May 2022 35 pages

Large Conductance Mechanosensitive Channel (mscL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Large Conductance Mechanosensitive Channel (mscL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Large Conductance Mechanosensitive Chan...

May 2022 35 pages

Laryngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Laryngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Laryngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 84 pages

Lennox-Gastaut Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lennox-Gastaut Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lennox-Gastaut Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 44 pages

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Leptomeningeal Disease (Neoplastic...

May 2022 54 pages

Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Letterer-Siwe...

May 2022 38 pages

Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte-Macrophage Immunoglobulin Like Receptor 10 or CD85d or LILRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte-Macrophage Immunoglobulin Like Receptor 10 or CD85d or LI...

May 2022 43 pages

Leukotriene B4 (LTB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Leukotriene B4 (LTB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Leukotriene B4 (LTB4) Drugs in Development by Therapy Areas and Ind...

May 2022 36 pages

Lewy body Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lewy body Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lewy body Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 68 pages